P3 Health Partners Inc (PIII)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Last updated: Nov 16, 2026 at 4:00 PM ET
P3 Health Partners Inc (PIII) Financials: Revenue, Profit and Cash Flow
P3 Health Partners reported revenue of $1.46B for the fiscal year ended Dec 31, 2025, down 2.8% from the year before. That year, net income was -$147.95M with a net margin of -10.1%, operating cash flow was -$91.24M and free cash flow was -$91.32M. The quarter ended Sep 30, 2026 had revenue of $396.34M and net income of $30.78M.
Revenue and Margins
The operating margin was -18.5% in the fiscal year ended Dec 2025. Over the 7 years to Dec 2025, revenue grew from $87.70M, a compound annual rate of 49.4%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1.46B | -2.8% | -9.9% | -18.5% | -10.1% |
| Dec 2024 | $1.50B | +18.5% | 100.0% | -21.4% | -20.7% |
| Dec 2023 | $1.27B | +20.7% | 100.0% | -13.3% | -14.7% |
| Dec 2022 | $1.05B | N/A | 100.0% | -148.7% | -148.8% |
| Dec 2021 | N/A | N/A | N/A | N/A | N/A |
| Dec 2020 | $491.06M | +237.5% | 100.0% | -5.8% | -6.4% |
| Dec 2019 | $145.48M | +65.9% | 100.0% | -27.2% | -28.8% |
| Dec 2018 | $87.70M | N/A | 100.0% | -56.7% | -49.9% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.46B | $1.50B | $1.27B | $1.05B | N/A | $491.06M | $145.48M | $87.70M |
| Cost of revenue | $1.60B | $0 | $0 | $0 | N/A | $0 | $0 | N/A |
| Gross profit | -$144.32M | $1.50B | $1.27B | $1.05B | N/A | $491.06M | $145.48M | $87.70M |
| Operating income | -$270.30M | -$320.66M | -$167.93M | -$1.56B | N/A | -$28.59M | -$39.54M | -$49.71M |
| Net income | -$147.95M | -$310.38M | -$186.43M | -$1.56B | N/A | -$31.41M | -$41.97M | -$43.80M |
| EBITDA | -$186.14M | -$168.15M | -$80.60M | -$1.46B | N/A | -$27.86M | -$39.04M | -$49.37M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $396.34M | $386.38M | $386.39M | $384.81M | $345.25M | $355.79M | $373.23M | $329.31M | $362.12M | $379.16M | $388.49M | $346.86M |
| Gross profit | $396.34M | $386.38M | $386.39M | $384.81M | $345.25M | $355.79M | $373.23M | $329.31M | $362.12M | $379.16M | $388.49M | $346.86M |
| Operating income | $22.98M | $41.23M | $8.24M | -$153.87M | -$44.22M | -$34.12M | -$38.09M | -$88.15M | -$106.99M | -$31.33M | -$43.83M | -$64.26M |
| Net income | $30.78M | $15.65M | $3.04M | -$165.71M | -$69.46M | -$43.66M | -$44.25M | -$141.86M | -$102.85M | -$28.77M | -$49.61M | -$69.11M |
Balance Sheet
As of Dec 2025, total debt of $273.41M exceeded cash and equivalents by $248.40M. Shareholder equity was negative, at -$155.23M, as total liabilities of $796.88M exceeded total assets of $656.64M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $656.64M | $656.64M | $860.97M | $876.57M | $2.36B | $106.44M | $65.61M | N/A |
| Current assets | $133.08M | $133.08M | $166.02M | $100.69M | $199.86M | $90.88M | $52.35M | N/A |
| Cash and equivalents | $25.01M | $25.01M | $36.32M | $17.54M | $140.48M | $36.26M | $32.59M | N/A |
| Total liabilities | $796.88M | $796.88M | $427.31M | $353.91M | $299.94M | $145.96M | $121.54M | N/A |
| Short-term debt | $45.04M | $45.04M | $0 | $1.60M | $3.63M | $89.99K | $3.25M | N/A |
| Long-term debt | $228.37M | $228.37M | $108.32M | $94.42M | $80.00M | $45.39M | $15.00M | N/A |
| Shareholder equity | -$155.23M | -$155.23M | $142.13M | $5.85M | $273.55M | -$130.04M | -$42.05M | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $669.72M | $654.39M | $674.16M | $656.64M | $683.56M | $731.59M | $783.87M | $783.42M | $833.33M | $892.76M | $855.92M | $860.97M |
| Total liabilities | $469.00M | $516.75M | $807.32M | $796.88M | $664.64M | $644.41M | $662.79M | $633.89M | $569.42M | $527.93M | $470.49M | $427.31M |
| Cash and equivalents | $43.90M | $21.27M | $25.50M | $25.01M | $37.71M | $38.58M | $40.08M | $38.82M | $62.96M | $73.09M | $27.30M | $36.32M |
| Shareholder equity | $107.27M | $72.19M | -$144.91M | -$155.23M | -$18.69M | $44.46M | $63.25M | $75.94M | $120.51M | $166.84M | $146.60M | $142.13M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$91.24M | -$110.13M | -$76.03M | -$126.02M | -$66.47M | -$24.60M | -$28.29M | -$29.24M |
| Capital expenditures | $79.00K | $0 | $1.83M | $2.23M | $3.41M | $2.93M | $1.45M | $3.31M |
| Free cash flow | -$91.32M | -$110.13M | -$77.86M | -$128.25M | -$69.88M | -$27.52M | -$29.74M | -$32.54M |
| Dividends paid | N/A | N/A | N/A | N/A | N/A | $180.00K | N/A | N/A |
| Investing cash flow | $129.00K | $14.53M | -$1.83M | -$7.73M | -$56.06M | -$3.17M | -$3.86M | -$4.60M |
| Financing cash flow | $72.81M | $98.77M | $100.33M | $11.38M | $223.47M | $34.76M | $63.62M | $33.25M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$685.00K | -$61.91M | -$27.47M | -$25.73M | -$15.41M | -$16.63M | -$33.47M | -$22.62M | -$10.24M | -$20.03M | -$15.88M | -$7.59M |
| Capital expenditures | N/A | N/A | $0 | $198.00K | $119.00K | $0 | $0 | $0 | $0 | $0 | $212.00K | $387.00K |
| Free cash flow | N/A | N/A | -$27.47M | -$25.93M | -$15.53M | -$16.63M | -$33.47M | -$22.62M | -$10.24M | -$20.03M | -$16.09M | -$7.97M |
Frequently Asked Questions About PIII
What is P3 Health Partners' annual revenue?
P3 Health Partners reported revenue of $1.46B for the fiscal year ended Dec 31, 2025.
How fast is P3 Health Partners' revenue growing?
Revenue was down 2.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 11.6%.
Is P3 Health Partners profitable?
No. P3 Health Partners reported net income of -$147.95M for the fiscal year ended Dec 31, 2025, with a net margin of -10.1%.
How much free cash flow does PIII generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$91.24M minus capital expenditures of $79.00K produced free cash flow of -$91.32M.
How much debt does P3 Health Partners have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $228.37M, short-term debt of $45.04M and cash and equivalents of $25.01M.
PIII pages: Overview, Earnings, Forecast, Financials, Competitors